Human IgG antibody Laboratories manufactures the medicine for spike protien reagents distributed by Genprice. The Medicine For Spike Protien reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Medicine products are available in stock. Specificity: Medicine Category: For Group: Spike Protien
Mouse antibody for MERS coronavirus spike 1 |
|
Virostat |
100 ug |
EUR 386.26 |
|
Description: This is purified Mouse monoclonal antibody against MERS coronavirus spike 1 for WB, ELISA. |
Mouse antibody for MERS coronavirus spike 1 |
|
Virostat |
100 ug |
EUR 386.26 |
|
Description: This is purified Mouse monoclonal antibody against MERS coronavirus spike 1 for WB, ELISA. |
Spike Protien information
SARS Spike Antibody |
|
24218-100ul |
SAB |
100ul |
EUR 468 |
SARS Spike Antibody |
|
24219-100ul |
SAB |
100ul |
EUR 468 |
SARS Spike Antibody |
|
24318-100ul |
SAB |
100ul |
EUR 468 |
SARS Spike Antibody |
|
20-abx137184 |
Abbexa |
-
EUR 1262.40
-
EUR 1846.80
-
EUR 2064.00
|
|
|
|
SARS Spike Antibody |
|
20-abx137200 |
Abbexa |
-
EUR 1412.40
-
EUR 2264.40
-
EUR 2665.20
|
|
|
|
COVID-19 Spike Protein a.a. 800 to 1000 |
|
00222-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
|
|
Description: COVID-19 Spike Protein a.a. 800 to 1000 |
Mouse Monoclonal Anti-SARS Spike Protein IgG |
|
AB-15710 |
Alpha Diagnostics |
20 ug |
EUR 489.6 |
COVID-19 Spike S1 protein a.a. 1 to 800 |
|
00226-V-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
|
|
Description: COVID-19 Spike S1 protein a.a. 1 to 800 |
MERS Spike S1 Recombinant protein |
|
39-102 |
ProSci |
0.1 mg |
EUR 556.8 |
|
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis. |
